Thermo Fisher Scientific opens Advanced Therapies Collaboration Center in greater San Diego
Thermo Fisher Scientific Inc. announced the grand opening of its Advanced Therapies Collaboration Center (ATxCC) in Carlsbad, Calif. This advanced facility is designed to accelerate the development and commercialization of cell therapies, specifically by supporting biotech, biopharma and translational customers developing cell-based immunotherapies.
Through this new center, cell therapy developers can leverage Thermo Fisher’s product and technology portfolio and deep process optimization knowledge to create comprehensive, end-to-end manufacturing workflows that can scale to enable clinical and commercial success.
Partnering closely with Thermo Fisher, cell therapy developers can receive the essential resources and support they need to transition to Current Good Manufacturing Practices (cGMP manufacturing). This collaboration helps navigate go-to-market obstacles.
Key ATxCC program benefits include:
- Access to innovative technologies: Developers gain access to Thermo Fisher laboratory equipment and analytical solutions – even before these technologies are available to the broader market.
- Protocol and process optimization support: Specialized scientists and engineers facilitate support in creating optimized manufacturing processes and protocols utilizing Thermo Fisher products, helping ensure they are scalable and robust.
- Ongoing support as therapeutic programs evolve: Dedicated regulatory, quality, and partnership management teams assist developers in growing and advancing their cell therapy programs by addressing new challenges and enabling platform-specific support.
For more information about Thermo Fisher’s advanced therapies collaboration center program, please visit https://www.thermofisher.com/celltherapycollaborations.
